Altogether, this data suggests that the activation of Rac1 and Cdc42 is critical for breast cancer extravasation and metastatic colonization, and that ZINC69391 may provide a promising therapeutic option for aggressive breast cancer. This evidence concerns the gene RAC1 and breast carcinoma.